HIGH-RISK NEUROBLASTOMA
Clinical trials for HIGH-RISK NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for HIGH-RISK NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new combo tackles tough childhood cancer
Disease control OngoingThis study tests whether adding two immunotherapy drugs (dinutuximab and sargramostim) to standard chemotherapy is safe and effective for children with high-risk neuroblastoma. About 42 children with newly diagnosed disease will receive this combination during early treatment. Th…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New pill may help kids with tough nerve cancer stay cancer-free longer
Disease control OngoingThis study looks at whether a drug called eflornithine can help children with high-risk neuroblastoma live longer without the cancer coming back. About 20 children who have already finished standard treatment and immunotherapy will take eflornithine pills. Researchers will track …
Matched conditions: HIGH-RISK NEUROBLASTOMA
Sponsor: Shanghai Children's Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New combo therapy shows promise for kids with relapsed neuroblastoma
Disease control OngoingThis study tests whether adding eflornithine (DFMO) to a standard chemo-immunotherapy regimen (irinotecan, temozolomide, and dinutuximab) helps children whose neuroblastoma has returned or stopped responding to treatment. About 94 children will be randomly assigned to receive the…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Can we spot late side effects in neuroblastoma survivors? new study aims to find out
Knowledge-focused OngoingThis study looks at whether it's possible to screen for long-term health problems in people who survived high-risk neuroblastoma. Researchers will check if at least 66% of eligible survivors complete a full set of health tests. The goal is to understand what health issues arise y…
Matched conditions: HIGH-RISK NEUROBLASTOMA
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 02:00 UTC